1st Quarter - Report

ABIOMED, INC for ABIOMED, INC

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- Issues relating to the reauthorization of MDUFA V - Education on the heart muscle recovery and support for continued diversity CV clinical trials - Issues relating to the supply chain for medical products - Education on FDA breakthrough medical device issues and use of RWE

LobbyistCovered position, as disclosed
DANIELLE MITCHELL Office of Representative Gwen Graham (D-FL), Intern, 8/2016-12/2016 Horizon Therapetuics, Fellow, 6/2017-10/2017 California Life Science Association CLSA), Manager GA, 10/2017-4/2021
MELISSA DODSON SCHOOLEY —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.